Stereotactic Body Radiation Improves Lung Cancer Survival (November 9, 2012)
Stereotactic body radiation for early-stage, inoperable non-small cell lung cancer yields high overall survival rates and low toxicity compared to conventional radiotherapy, according to the results of... Continue Reading
Researchers have identified a large variety of genetic alterations that appear to be responsible for the development and growth of squamous cell lung cancer, according to the results of a study published... Continue Reading
Younger patients with non-small cell lung cancer (NSCLC) are more likely to receive treatment than older patients, regardless of overall health and prognosis, according to the results of a study published... Continue Reading
Among older patients who undergo surgery for locally advanced, non-small-cell lung cancer, many receive postoperative radiation therapy. The radiation therapy, however, may not improve treatment outcomes.... Continue Reading
Among patients with Stage III non-small cell lung cancer, treatment with a higher dose of radiation therapy does not result in better overall survival than a standard dose of radiation therapy. These results... Continue Reading
Compared with the demographics of lung cancer in the United States, the elderly, minorities, and women remain vastly under-represented in lung cancer clinical trials. These results were presented at the... Continue Reading
A genetic test performed on a sample of tumor tissue helps predict survival among patients with early, non-squamous, non-small cell lung cancer (NSCLC) who are treated with surgery only. Patients with... Continue Reading
Estimates of lung tumor size based on computed tomography (CT) scans can vary from scan to scan even when the actual size of the tumor remains the same. These results were published in the Journal of Clinical... Continue Reading
Liposomal cisplatin (Nanoplatin®), a chemotherapy drug still in clinical trials, does not cause damage to the kidneys and appears to provide at least equal anti-cancer effects as cisplatin (Platinol®)... Continue Reading
For patients with Stage III non-small cell lung cancer, prophylactic (preventive) radiation therapy to the brain reduces the risk of brain metastases but carries a risk of memory problems and doesn’t... Continue Reading